Literature DB >> 19070927

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.

Joel Gozlan1, Karine Lacombe, Elyanne Gault, Gilles Raguin, Pierre-Marie Girard.   

Abstract

Multiple hepatitis co-infections are frequent in HIV-infected patients, often resulting in severe liver diseases that are difficult to treat. We report here the complete resolution of a chronic hepatitis B and D co-infection in a patient who was also infected with HCV and HIV. This cure was observed after 24weeks of combination therapy associating pegylated-IFN and ribavirin, which was initially given to treat HCV. An unexpected and extensive HDV replication was observed in this patient after HBs Ag had cleared from the serum, which was followed by a stable halt in HDV replication. Implications of this unusual observation will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070927     DOI: 10.1016/j.jhep.2008.05.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B.

Authors:  B Rossetti; C Bianco; A De Luca
Journal:  Infection       Date:  2011-10-15       Impact factor: 3.553

2.  Cost-Effectiveness of Peg-Interferon, Interferon and Oral Nucleoside Analogues in the Treatment of Chronic Hepatitis B and D Infections in China.

Authors:  Ashish Goyal; John M Murray
Journal:  Clin Drug Investig       Date:  2016-08       Impact factor: 2.859

3.  Development of mathematical models for the analysis of hepatitis delta virus viral dynamics.

Authors:  Bruno C de Sousa; Celso Cunha
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

4.  Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach.

Authors:  Abida Shehzadi; Shahid Ur Rehman; Muhammad Idrees
Journal:  Virol J       Date:  2011-02-08       Impact factor: 4.099

5.  The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012.

Authors:  Mohammad Motamedifar; Mohammad Taheri; Kamran Bagheri Lankarani; Mina Gholami; Mahmood Amini Lari; Hossein Faramarzi; Jamal Sarvari
Journal:  Iran J Med Sci       Date:  2015-09

6.  Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin.

Authors:  Janine Hartl; Claudia Ott; Gabriele Kirchner; Bernd Salzberger; Reiner Wiest
Journal:  Clin Pract       Date:  2012-07-10

7.  Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report.

Authors:  Adriane Maira Delicio; Paulo Afonso Martins Abati; Aline Gonzalez Vigani
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.